PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 67 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $494,500 | +110.8% | 21,500 | 0.0% | 0.00% | – |
| Q4 2022 | $234,565 | -81.9% | 21,500 | -86.9% | 0.00% | -100.0% |
| Q2 2022 | $1,298,000 | -58.7% | 164,075 | +23.6% | 0.00% | -50.0% |
| Q1 2022 | $3,144,000 | -31.8% | 132,734 | -1.5% | 0.00% | -33.3% |
| Q4 2021 | $4,611,000 | +429.4% | 134,793 | +174.1% | 0.00% | +200.0% |
| Q3 2021 | $871,000 | -73.9% | 49,171 | -33.8% | 0.00% | -66.7% |
| Q2 2021 | $3,333,000 | +73.3% | 74,260 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $1,923,000 | +28.4% | 74,260 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $1,498,000 | +3.2% | 74,260 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $1,452,000 | +8.5% | 74,260 | -2.0% | 0.00% | 0.0% |
| Q2 2020 | $1,338,000 | +85.8% | 75,790 | -25.8% | 0.00% | +100.0% |
| Q1 2020 | $720,000 | +42.0% | 102,098 | +41.8% | 0.00% | – |
| Q4 2019 | $507,000 | -63.4% | 72,001 | -36.4% | 0.00% | -100.0% |
| Q3 2019 | $1,385,000 | -7.9% | 113,276 | -8.7% | 0.00% | 0.0% |
| Q2 2019 | $1,503,000 | +55.4% | 124,090 | +61.3% | 0.00% | 0.0% |
| Q1 2019 | $967,000 | – | 76,915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $67,646,434 | 21.00% |
| COWEN AND COMPANY, LLC | 1,657,551 | $45,781,558 | 3.80% |
| Kynam Capital Management, LP | 975,298 | $26,937,731 | 3.70% |
| BVF INC/IL | 3,775,900 | $104,290,358 | 2.91% |
| RTW INVESTMENTS, LP | 5,415,514 | $149,576,497 | 2.85% |
| Cormorant Asset Management, LP | 1,500,000 | $41,430,000 | 2.32% |
| Ghost Tree Capital, LLC | 225,000 | $6,214,500 | 2.05% |
| 683 Capital Management, LLC | 814,000 | $22,482,680 | 1.62% |
| Perceptive Advisors | 1,469,761 | $40,594,799 | 1.18% |
| Artia Global Partners LP | 112,340 | $3,102,831 | 1.07% |